ClinicalTrials.Veeva

Menu

Decreasing Postoperative Complications by Goal-Directed Fluid Therapy During Esophageal Resection

U

University Hospital, Linkoeping

Status and phase

Completed
Phase 4

Conditions

Esophageal Cancer

Treatments

Other: fluid optimisation

Study type

Interventional

Funder types

Other

Identifiers

NCT01416077
USANOP001

Details and patient eligibility

About

Surgery for cancer of the esophagus is associated with a high risk of postoperative complications. It has been shown that the risk of postoperative complications can be decreased by optimising the amount and type of infusion fluids given during surgery, steered by measurement of cardiac stroke volume, mostly done with a device called esophageal Doppler. This device can however not be used during this type of surgery. This study wants to test the hypothesis that postoperative complications in patients operated for esophageal cancer can be partially prevented by using a goal directed strategy for the administration of fluids and drugs influencing the heart and vessels, based on measurement of stroke volume by pulse wave analysis (FloTrac).

Enrollment

64 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Patients scheduled for transthoracic esophageal resection because of malignancy, without colonic interposition who leave informed consent

Exclusion criteria

  • ASA 4 or 5
  • Atrial Fibrillation
  • Significant Aortic or Mitral Valve Insufficiency
  • Preoperative planned extensive monitoring beyond CVP, arterial blood pressure, diuresis, ECG and other standard monitors

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

64 participants in 2 patient groups

standard treatment
No Intervention group
Description:
Fluid and inotropic drugs are given based on conventional parameters such as blood pressure and heart rate as judged by the individual anesthesiologists judgement.
goal-directed fluid treatment
Active Comparator group
Description:
Stroke Volume and Cardiac Index are measured with the Flotrac/Vigileo system and circulation is optimised
Treatment:
Other: fluid optimisation

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems